European court grants preliminary injunction against Pendulum and iHerb based on Caelus patent
In summary injunction proceedings, the Unified Patent Court has provisionally ordered Pendulum and iHerb to stop selling products containing the bacterium for the patented use in various European markets (Belgium, Denmark, Germany, France, Italy, the Netherlands, Sweden and Switzerland)....
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.